Continuous Glucose Monitoring
Continuous Glucose Monitoring is a medical device with 69 clinical trials. Currently 12 active trials ongoing. Historical success rate of 94.7%.
Success Metrics
Based on 36 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
36 of 40 finished
10.0%
4 ended early
12
trials recruiting
69
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
CGM-Based Glycemic Analysis After ESI
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Diabetes In Asians at Risk in Youth
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Clinical Trials (69)
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
CGM-Based Glycemic Analysis After ESI
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
Diabetes In Asians at Risk in Youth
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
Mechanisms of Hypoglycemia in Patients Without Diabetes
Continuous Glucose Monitoring (CGM) in Prediabetes
Automated Insulin Delivery in Adults With Advanced Kidney Disease
A Study on the Effect of CGM Alone on Glycemic Metrics in Type 2 Diabetes Patients Not Using Insulin, Without Additional Interventions
Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome
The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
Accuracy of Interstitial Continuous Glucose Sensors in Neonates
Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.
Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone
PRediction Of Glycemic RESponse Study
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 69